The US Food and Drug Administration is contemplating a new requirement for blood banks to implement a test capable of detecting malaria-causing parasites in certain donors' blood. This initiative aims to prevent transfusion-related malaria cases while ensuring that eligible individuals can continue donating blood.
Malaria is a significant global health concern, with 249 million cases and over 608,000 deaths reported in 2022 by the World Health Organization. Although malaria is not a major threat to the US blood supply, the increasing number of Americans traveling to malaria-endemic regions raises concerns about potential transmission.
